Galapagos NV
GLPG
#4542
Rank
HK$16.55 B
Marketcap
HK$250.72
Share price
-1.60%
Change (1 day)
25.46%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -HK$2.52

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$2.66. In 2024 the company made an earnings per share (EPS) of HK$9.13 a decrease over its 2023 EPS that were of HK$27.79.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.52-127.61%
2024HK$9.13-67.16%
2023HK$27.79-199.64%
2022-HK$27.8999.03%
2021-HK$14.02-68.98%
2020-HK$45.18-298.06%
2019HK$22.81-554.64%
2018-HK$5.02-77.18%
2017-HK$21.99-326.21%
2016HK$9.72-134.19%
2015-HK$28.43-371.34%
2014HK$10.48-445.98%
2013-HK$3.0332.88%
2012-HK$2.28-82.07%
2011-HK$12.71-817.9%
2010HK$1.7712.73%
2009HK$1.57-120.79%
2008-HK$7.56-37.67%
2007-HK$12.1239.64%
2006-HK$8.6828.17%
2005-HK$6.776.25%
2004-HK$6.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.23-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$29.36-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$18.73-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$16.18-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$57.23-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$41.90-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$29.51-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$4.78 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$9.71-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel